<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04003909</url>
  </required_header>
  <id_info>
    <org_study_id>N-147-2018</org_study_id>
    <nct_id>NCT04003909</nct_id>
  </id_info>
  <brief_title>Erector Spinae Plane Block for Postoperative Pain Control in Hip Replacement Surgeries</brief_title>
  <official_title>Effectiveness of Ultrasound-guided Erector Spinae Plane Block for Postoperative Pain Control in Hip Replacement Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bassant M. Abdelhamid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      ESP block advantages include its simplicity, easy identifiable ultrasonographic landmarks and
      low risk for serious complications as injection is into tissue plane that is distant from
      pleura, major blood vessels and discrete nerves. Coupled with the fact that the erector
      spinae muscle and ESP extend down to the lumbar spine, ESP block was hypothesized to be
      performed at the level of L4. In a recent case report, ultrasound guided ESP block was
      successfully performed at L4 transverse process level for postoperative analgesia after total
      hip arthroplasty. However, confirmation of the efficacy of ESP block in hip replacement
      surgeries needed more investigation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be performed in Cairo university hospital. Thirty adult patients of both
      sexes scheduled for hip replacement surgery under spinal anesthesia will be enrolled in the
      study.

      All patients meeting the inclusion criteria will be randomly assigned to one of 2 groups, 15
      per group:

      Group E, ESP group (n=15): prior to surgical incision, patients will have ultrasound guided
      ESP block before spinal anesthesia.

      Group C, Control group (n=15): prior to surgical incision, patients will have spinal
      Anesthesia without ESP block .

      Patients will be randomly allocated by a computer-generated table into one of the study
      groups, the randomization sequence will be concealed in sealed opaque envelopes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 5, 2019</start_date>
  <completion_date type="Actual">November 6, 2019</completion_date>
  <primary_completion_date type="Actual">October 5, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total morphine consumption</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>Total morphine consumption in rescue boluses during 1st 24 hrs postoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analogue scale</measure>
    <time_frame>30 minutes,2,4, 6, 12, and 24 hours postoperative.</time_frame>
    <description>Visual analogue scale at the following intervals:30 minutes,2,4, 6, 12, and 24 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of analgesia</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>defined as the time interval from completion of local anesthetic administration till first need of rescue analgesic in the form of iv morphine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of complications</measure>
    <time_frame>24 hours</time_frame>
    <description>Nerve injury, Hematoma formation, LA toxicity, Intravascular injection.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>ESP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will have ultrasound guided ESP block before spinal anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will have spinal Anesthesia without ESP block</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ultrasound-guided Erector spinae plane block</intervention_name>
    <description>The patients will be in lateral position. A curvilinear array ultrasound probe will be placed in a transverse orientation at L4 level to identify the tip of the L4 transverse process. Local anesthetic infiltration of the superficial tissues, an echogenic 22-G block needle will be inserted inplane to the ultrasound beam in a cranial-to-caudal direction until contact made with the L4 transverse process. Correct location of the needle tip in the fascial plane deep to erector spinae muscle will be confirmed by injecting 0.5-1ml saline and seeing the fluid lifting the erector spinae muscle off the transverse process while not distending the muscle. A total volume of 20ml bupivicaine 0.25% and 20 ml xylocaine 1% will be injected into the ESP on the affected side.</description>
    <arm_group_label>ESP group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>subarachonoid block</intervention_name>
    <description>Local anesthesia 2ml of lidocaine 2% will be applied intradermally to the needle entrance point. A 22-G block needle will be inserted, free cerebrospinal fluid flow will be observed and 20mg of hyperbaric bupivacaine 0.5% and 10Î¼g of fentanyl will be injected for 30 seconds.</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>ESP group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged from 40 to 65 years old

          -  Both sexes.

          -  ASA I-II.

          -  Undergo hip replacement surgery.

          -  Body mass index (BMI) from 18 to 35 kg/m2.

        Exclusion Criteria:

          -  Patient refusal.

          -  Contraindication to regional anesthesia (bleeding disorder, use of any anticoagulants,
             local infection, etc. )

          -  BMI &gt; 35.

          -  Known allergy to local anesthetics.

          -  ASA III-IV.

          -  Patients with difficulty in evaluating their level of pain.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ashraf Rady, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amr abdelnasser</last_name>
    <role>Study Director</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Anesthesia Department</name>
      <address>
        <city>Cairo</city>
        <zip>1772</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Tulgar S, Selvi O, Senturk O, Ermis MN, Cubuk R, Ozer Z. Clinical experiences of ultrasound-guided lumbar erector spinae plane block for hip joint and proximal femur surgeries. J Clin Anesth. 2018 Jun;47:5-6. doi: 10.1016/j.jclinane.2018.02.014. Epub 2018 Mar 6.</citation>
    <PMID>29522966</PMID>
  </reference>
  <reference>
    <citation>Ueshima H, Otake H. Clinical experiences of ultrasound-guided erector spinae plane block for thoracic vertebra surgery. J Clin Anesth. 2017 May;38:137. doi: 10.1016/j.jclinane.2016.12.028. Epub 2017 Feb 17.</citation>
    <PMID>28372654</PMID>
  </reference>
  <reference>
    <citation>Hamilton DL, Manickam B. Erector spinae plane block for pain relief in rib fractures. Br J Anaesth. 2017 Mar 1;118(3):474-475. doi: 10.1093/bja/aex013.</citation>
    <PMID>28203765</PMID>
  </reference>
  <reference>
    <citation>Tulgar S, Kapakli MS, Senturk O, Selvi O, Serifsoy TE, Ozer Z. Evaluation of ultrasound-guided erector spinae plane block for postoperative analgesia in laparoscopic cholecystectomy: A prospective, randomized, controlled clinical trial. J Clin Anesth. 2018 Sep;49:101-106. doi: 10.1016/j.jclinane.2018.06.019. Epub 2018 Jun 15.</citation>
    <PMID>29913392</PMID>
  </reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>June 26, 2019</study_first_submitted>
  <study_first_submitted_qc>June 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2019</study_first_posted>
  <last_update_submitted>November 5, 2019</last_update_submitted>
  <last_update_submitted_qc>November 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Bassant M. Abdelhamid</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

